At TMT LLC, we recognize that our innovations are built on a foundation of intellectual property (IP) that drives our success in the biotechnology industry. Protecting our IP is essential for fostering innovation, ensuring safety, and delivering advanced therapeutic solutions to patients.
TMT LLC is dedicated to safeguarding its intellectual property rights through robust monitoring and enforcement strategies. We believe that strong IP protection not only benefits our organization but also enhances trust among our partners and stakeholders.
For inquiries related to intellectual property, including licensing opportunities, please contact us at info@tmtllc.us
Our organization is committed to protecting and advancing our innovative therapeutic platforms through robust intellectual property strategies. We secure patents for our groundbreaking technologies, including :
Our proprietary CAR T cell modifications, including CRISPR-based genetic edits and novel antigen-targeting strategies,
are protected to maintain our leadership in addressing the challenges posed by solid tumors.
Patented methods for producing minicircle-DNA, which exclude bacterial sequences, ensuring safer, more effective vaccines with sustained gene expression. Our proprietary vaccines targeting emerging viral variants are protected under our intellectual property portfolio.
We hold intellectual property rights for our innovative use of Sleeping Beauty gene transposition and minicircle DNA,
ensuring that our safer, more efficient therapies remain exclusive and secure.
Through diligent intellectual property management, we safeguard our innovations and ensure that they continue to provide cutting-edge solutions in vaccine technology and cancer immunotherapy.